※Title and date of other disclosure related to this one
2022-04-15 Resolutions for Convocation of General Meeting of Shareholders
2022-04-15 Closure of Register of Shareholders or Designation of Record Date
2022-05-27 Outcomes of Extraordinary General Meeting of Shareholders
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bioneer Corporation published this content on 27 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2022 08:48:14 UTC.
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and RNA interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Companyâs products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.